$TBTC
TABLE TRAC INC

2023 Q3 Form 10-Q Financial Statement

#000143774923022932 Filed on August 10, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $1.836M $2.437M
YoY Change -20.21% -0.91%
Cost Of Revenue $428.8K $566.5K
YoY Change -50.47% -64.64%
Gross Profit $1.407M $1.870M
YoY Change -1.97% 118.18%
Gross Profit Margin 76.65% 76.75%
Selling, General & Admin $1.292M $1.202M
YoY Change 18.17% 6.01%
% of Gross Profit 91.82% 64.25%
Research & Development $10.00K $16.28K
YoY Change
% of Gross Profit 0.71% 0.87%
Depreciation & Amortization $0.00 $0.00
YoY Change -100.0% -100.0%
% of Gross Profit 0.0% 0.0%
Operating Expenses $1.292M $1.202M
YoY Change 18.17% 6.01%
Operating Profit $115.1K $668.6K
YoY Change -66.34% -341.97%
Interest Expense $80.00K $84.15K
YoY Change 201.77% 443.96%
% of Operating Profit 69.48% 12.59%
Other Income/Expense, Net $0.00 $4.280K
YoY Change
Pretax Income $194.0K $757.0K
YoY Change -47.37% -390.23%
Income Tax $22.00K $185.6K
% Of Pretax Income 11.34% 24.52%
Net Earnings $172.0K $571.4K
YoY Change -40.72% -335.79%
Net Earnings / Revenue 9.37% 23.45%
Basic Earnings Per Share $0.04 $0.13
Diluted Earnings Per Share $0.04 $0.12
COMMON SHARES
Basic Shares Outstanding 4.633M 4.632M
Diluted Shares Outstanding 4.606M 4.618M

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.470M $4.754M
YoY Change -5.2% 7.97%
Cash & Equivalents $4.413M $4.693M
Short-Term Investments $60.00K $60.76K
Other Short-Term Assets $450.0K $753.8K
YoY Change 9.53% 102.09%
Inventory $2.769M $1.805M
Prepaid Expenses $453.4K $753.7K
Receivables $2.070M $1.966M
Other Receivables $0.00 $36.68K
Total Short-Term Assets $9.766M $9.316M
YoY Change 11.12% 16.2%
LONG-TERM ASSETS
Property, Plant & Equipment $25.11K $128.7K
YoY Change 6415.44%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $130.0K $149.2K
YoY Change 22.38% 27.79%
Other Assets
YoY Change
Total Long-Term Assets $1.410M $1.458M
YoY Change 22.8% 19.84%
TOTAL ASSETS
Total Short-Term Assets $9.766M $9.316M
Total Long-Term Assets $1.410M $1.458M
Total Assets $11.18M $10.77M
YoY Change 12.47% 16.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $170.0K $186.4K
YoY Change -54.28% -51.49%
Accrued Expenses $190.0K $123.0K
YoY Change 137.03% 78.7%
Deferred Revenue $817.9K $701.6K
YoY Change -35.44% -24.29%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.254M $1.011M
YoY Change -27.07% -26.72%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $160.0K $64.89K
YoY Change 40.63% -35.44%
Total Long-Term Liabilities $160.0K $64.89K
YoY Change 40.63% -35.44%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.254M $1.011M
Total Long-Term Liabilities $160.0K $64.89K
Total Liabilities $1.827M $1.584M
YoY Change -9.7% -3.55%
SHAREHOLDERS EQUITY
Retained Earnings $7.284M $7.159M
YoY Change 19.85% 23.68%
Common Stock $2.288M $2.257M
YoY Change 10.58% 10.75%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $9.349M $9.190M
YoY Change
Total Liabilities & Shareholders Equity $11.18M $10.77M
YoY Change 12.47% 16.68%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income $172.0K $571.4K
YoY Change -40.72% -335.79%
Depreciation, Depletion And Amortization $0.00 $0.00
YoY Change -100.0% -100.0%
Cash From Operating Activities -$210.0K -$482.2K
YoY Change -167.45% -62.83%
INVESTING ACTIVITIES
Capital Expenditures $30.00K
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$30.00K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -50.00K -43.32K
YoY Change
NET CHANGE
Cash From Operating Activities -210.0K -482.2K
Cash From Investing Activities -30.00K
Cash From Financing Activities -50.00K -43.32K
Net Change In Cash -290.0K -525.5K
YoY Change -193.14% -59.49%
FREE CASH FLOW
Cash From Operating Activities -$210.0K -$482.2K
Capital Expenditures $30.00K
Free Cash Flow -$240.0K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4756734
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4756734
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4632988
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4621988
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
123746
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
134746
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
2273 usd
CY2023Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
203378 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
100000
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-32987
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
88-0336568
dei Entity Address Address Line1
EntityAddressAddressLine1
6101 Baker Road, Suite 206
dei Entity Address City Or Town
EntityAddressCityOrTown
Minnetonka
dei Entity Address State Or Province
EntityAddressStateOrProvince
MN
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
55345
dei City Area Code
CityAreaCode
952
dei Local Phone Number
LocalPhoneNumber
548-8877
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
4632988
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4693416 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4786923 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1965874 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1868488 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
1805363 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
1560175 usd
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
753746 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
417254 usd
CY2023Q2 tbtc Salestype Lease Net Investment In Lease After Allowance For Credit Loss Current
SalestypeLeaseNetInvestmentInLeaseAfterAllowanceForCreditLossCurrent
60756 usd
CY2022Q4 tbtc Salestype Lease Net Investment In Lease After Allowance For Credit Loss Current
SalestypeLeaseNetInvestmentInLeaseAfterAllowanceForCreditLossCurrent
59173 usd
CY2023Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
36674 usd
CY2022Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
124198 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
9315829 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
8816211 usd
CY2023Q2 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
1180227 usd
CY2022Q4 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
1523793 usd
CY2023Q2 tbtc Salestype Lease Net Investment In Lease After Allowance For Credit Loss Noncurrent
SalestypeLeaseNetInvestmentInLeaseAfterAllowanceForCreditLossNoncurrent
149190 usd
CY2022Q4 tbtc Salestype Lease Net Investment In Lease After Allowance For Credit Loss Noncurrent
SalestypeLeaseNetInvestmentInLeaseAfterAllowanceForCreditLossNoncurrent
176444 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
128677 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
157802 usd
CY2023Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
1458094 usd
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
1858039 usd
CY2023Q2 us-gaap Assets
Assets
10773923 usd
CY2022Q4 us-gaap Assets
Assets
10674250 usd
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
186351 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
417853 usd
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
66701 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
10665 usd
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
701635 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1485622 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
56281 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
55942 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1010968 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1970082 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
64889 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
97476 usd
CY2023Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
508000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
331000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
1583857 usd
CY2022Q4 us-gaap Liabilities
Liabilities
2398558 usd
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
4633 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
4622 usd
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2251945 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2207030 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
7158555 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
6297639 usd
CY2023Q2 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
9415133 usd
CY2022Q4 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
8509291 usd
CY2023Q2 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
225067 usd
CY2022Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
233599 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
9190066 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
8275692 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10773923 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10674250 usd
CY2023Q2 us-gaap Revenues
Revenues
2436592 usd
CY2022Q2 us-gaap Revenues
Revenues
2459014 usd
us-gaap Revenues
Revenues
4739003 usd
us-gaap Revenues
Revenues
5810838 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
566507 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
1601900 usd
us-gaap Cost Of Revenue
CostOfRevenue
988348 usd
us-gaap Cost Of Revenue
CostOfRevenue
2263513 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
1870085 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
857114 usd
us-gaap Gross Profit
GrossProfit
3750655 usd
us-gaap Gross Profit
GrossProfit
3547325 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1201533 usd
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1133411 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2745319 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2219806 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
668552 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-276297 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
1005336 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
1327519 usd
CY2023Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
4283 usd
CY2022Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
4283 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
10611 usd
CY2023Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
84145 usd
CY2022Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
15473 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
172622 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
56386 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
756980 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-260824 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1182241 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1394516 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
185600 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-18500 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
275000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
375000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
571380 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-242324 usd
us-gaap Net Income Loss
NetIncomeLoss
907241 usd
us-gaap Net Income Loss
NetIncomeLoss
1019516 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.13
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.20
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.23
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.20
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.22
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4552450
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4521988
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4552220
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4521988
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4617648
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4521988
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4624436
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4548449
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
6527358 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
13707 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
1261840 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
7802905 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
31158 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-242324 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
7591739 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
8275692 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
25224 usd
CY2023Q1 us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
0 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
335861 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
8636777 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
25224 usd
CY2023Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
46325 usd
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3010 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
571380 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
9190066 usd
us-gaap Net Income Loss
NetIncomeLoss
907241 usd
us-gaap Net Income Loss
NetIncomeLoss
1019516 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
0 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
5904 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
177000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
171000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
50448 usd
us-gaap Share Based Compensation
ShareBasedCompensation
44865 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-246180 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1235249 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
245188 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-14404 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
336492 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-426540 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-25671 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-19390 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-234625 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
122812 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
56036 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-515 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-783987 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-649300 usd
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-87524 usd
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
522681 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-50192 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-583314 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3010 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
46325 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
-0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-43315 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-93507 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-583314 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4786923 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4945913 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4693416 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4362599 usd
us-gaap Stock Issued1
StockIssued1
7542 usd
us-gaap Stock Issued1
StockIssued1
0 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
29125 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
32575 usd
CY2023Q2 us-gaap Revenues
Revenues
2436592 usd
CY2022Q2 us-gaap Revenues
Revenues
2459014 usd
CY2023Q2 tbtc Percent Of Revenues
PercentOfRevenues
1.000 pure
CY2022Q2 tbtc Percent Of Revenues
PercentOfRevenues
1.000 pure
us-gaap Revenues
Revenues
4739003 usd
us-gaap Revenues
Revenues
5810838 usd
tbtc Percent Of Revenues
PercentOfRevenues
1.000 pure
tbtc Percent Of Revenues
PercentOfRevenues
1.000 pure
CY2023Q2 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
0 usd
CY2022Q2 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
69000 usd
CY2023Q2 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss
ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
2560191 usd
CY2022Q4 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss
ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
2781800 usd
CY2023Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
2273 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
1805363 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
1560175 usd
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
396880 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
32550 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0 usd
CY2023Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
2032719 usd
CY2022Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1930488 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
66845 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
62000 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1965874 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1868488 usd
CY2023Q2 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
1180227 usd
CY2022Q4 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
1523793 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
62000 usd
us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
16464 usd
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
11619 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
66845 usd
us-gaap Sales Type Lease Lease Income
SalesTypeLeaseLeaseIncome
20586 usd
us-gaap Sales Type Lease Lease Income
SalesTypeLeaseLeaseIncome
19390 usd
us-gaap Sales Type Lease Interest Income
SalesTypeLeaseInterestIncome
3864 usd
us-gaap Sales Type Lease Interest Income
SalesTypeLeaseInterestIncome
4677 usd
CY2023Q2 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Remainder Of Fiscal Year
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear
35850 usd
CY2023Q2 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Next Twelve Months
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths
71700 usd
CY2023Q2 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Two Years
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears
71700 usd
CY2023Q2 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Three Years
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears
26875 usd
CY2023Q2 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Four Years
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears
22800 usd
CY2023Q2 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived
228925 usd
CY2023Q2 us-gaap Sales Type And Direct Financing Leases Lease Receivable Undiscounted Excess Amount
SalesTypeAndDirectFinancingLeasesLeaseReceivableUndiscountedExcessAmount
18979 usd
CY2023Q2 us-gaap Sales Type And Direct Financing Leases Lease Receivable
SalesTypeAndDirectFinancingLeasesLeaseReceivable
209946 usd
CY2023Q2 tbtc Salestype Lease Net Investment In Lease After Allowance For Credit Loss
SalestypeLeaseNetInvestmentInLeaseAfterAllowanceForCreditLoss
60756 usd
CY2022Q4 tbtc Salestype Lease Net Investment In Lease After Allowance For Credit Loss
SalestypeLeaseNetInvestmentInLeaseAfterAllowanceForCreditLoss
59173 usd
CY2023Q2 tbtc Salestype Lease Net Investment In Lease After Allowance For Credit Loss Noncurrent
SalestypeLeaseNetInvestmentInLeaseAfterAllowanceForCreditLossNoncurrent
149190 usd
CY2022Q4 tbtc Salestype Lease Net Investment In Lease After Allowance For Credit Loss Noncurrent
SalestypeLeaseNetInvestmentInLeaseAfterAllowanceForCreditLossNoncurrent
176444 usd
CY2023Q2 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.05 pure
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
14617 usd
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
15570 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
29125 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
32575 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
32587 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
65683 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
35445 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
133715 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
12545 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
121170 usd
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y1M13D
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
70000
CY2021Q2 tbtc Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue
128726 usd
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
15000
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
22919 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
16500
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
37969 usd
CY2023Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
294000 usd
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
343000 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y4M20D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.96
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
153860 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
87500
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.04
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
129735 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
101500
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.97
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
85000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.52
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.01
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
500
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
5.29
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
0
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
100000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.96
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
85000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.52
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
87500
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.04
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
51500
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.52
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
571380 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-242324 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4552450
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4521988
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.13
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4617648
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4521988
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
907241 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1019516 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4552220
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4521988
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.20
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.23
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4624436
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4548449
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.20
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.22
CY2023Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
65198
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2022Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
72716
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
26000

Files In Submission

Name View Source Status
0001437749-23-022932-index-headers.html Edgar Link pending
0001437749-23-022932-index.html Edgar Link pending
0001437749-23-022932.txt Edgar Link pending
0001437749-23-022932-xbrl.zip Edgar Link pending
ex_530016.htm Edgar Link pending
ex_530017.htm Edgar Link pending
ex_530018.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tbltrc20230630_10q.htm Edgar Link pending
tbtc-20230630.xsd Edgar Link pending
tbtc-20230630_def.xml Edgar Link unprocessable
tbtc-20230630_lab.xml Edgar Link unprocessable
tbtc-20230630_pre.xml Edgar Link unprocessable
tbltrc20230630_10q_htm.xml Edgar Link completed
tbtc-20230630_cal.xml Edgar Link unprocessable